protein binding of drugs
Recently Published Documents


TOTAL DOCUMENTS

57
(FIVE YEARS 3)

H-INDEX

22
(FIVE YEARS 0)

2011 ◽  
pp. 145-166
Author(s):  
Antonia Kotsiou ◽  
Christine Tesseromatis

Author(s):  
Ramini Moonesinghe ◽  
Sue Mallett

The metabolism and excretion of many analgesic drugs will be altered in the presence of renal or hepatic impairment. Some analgesic drugs can cause renal or hepatic damage. Protein binding of drugs may be altered by hepatic reduction in production or uraemic displacement from binding sites. In renal disease, paracetamol is the simple analgesic of choice. Morphine can be used with care in mild to moderate renal disease, but fentanyl or oxycodone may be better alternatives. Non-steroidal anti-inflammatory drugs should be avoided in renal disease. In hepatic disease with significant impairment, doses of morphine must be reduced and the dosage interval lengthened. Fentanyl should be avoided in severe hepatic disease.


Sign in / Sign up

Export Citation Format

Share Document